|
Volumn 129, Issue 3, 2011, Pages 377-379
|
Topical timolol for periocular hemangioma: Report of further study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CORTICOSTEROID;
IMMUNOMODULATING AGENT;
PROPRANOLOL;
STEROID;
TIMOLOL;
ABSENCE OF SIDE EFFECTS;
ADRENAL CORTEX INSUFFICIENCY;
BEHAVIOR DISORDER;
BONE MARROW SUPPRESSION;
BRADYCARDIA;
BRONCHOSPASM;
CENTRAL RETINA ARTERY OCCLUSION;
CHILD;
CLINICAL ARTICLE;
CONGESTIVE HEART FAILURE;
DRUG MECHANISM;
EYELID;
GASTROINTESTINAL HEMORRHAGE;
GROWTH DISORDER;
HEART BLOCK;
HEART RATE;
HEMANGIOMA;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
HYPOTENSION;
IMMUNE DEFICIENCY;
INTRAOCULAR PRESSURE;
LETTER;
LIVER TOXICITY;
NEUROTOXICITY;
PERIOCULAR HEMANGIOMA;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
ADMINISTRATION, TOPICAL;
ADRENERGIC BETA-ANTAGONISTS;
EYELID NEOPLASMS;
FACIAL NEOPLASMS;
FEMALE;
HEMANGIOMA, CAPILLARY;
HUMANS;
INFANT;
TIMOLOL;
|
EID: 79952605358
PISSN: 00039950
EISSN: 15383601
Source Type: Journal
DOI: 10.1001/archophthalmol.2011.24 Document Type: Letter |
Times cited : (78)
|
References (6)
|